Physician profile
Eric G Walter
NPI 1063410470
$1,691.22
in general payments reported to CMS, 2019-2025
14 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $74.36 · 2021: $121 · 2022: $81.00 · 2023: $219 · 2024: $286 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $611.37 | 2022-2025 | Citrefix, Variax, Prostep Mica |
| Treace Medical Concepts, INC. | $292.23 | 2022-2025 | |
| Depuy Synthes Sales INC. | $121.44 | 2021 | |
| Osiris Therapeutics INC. | $119.67 | 2019 | |
| Advanced Oxygen Therapy INC. | $86.33 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $85.79 | 2019 | |
| Gotham Surgical Solutions & Devices, INC. | $70.59 | 2019-2025 | |
| Medtronic, INC. | $58.11 | 2024 | Intellis Adaptivestim |
| Axogen | $55.25 | 2019 | |
| Smith+Nephew, INC. | $49.72 | 2023-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $41.89 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Averitas Pharma INC. | $41.27 | 2025 | Qutenza |
| Kerecis Limited | $29.26 | 2019 | |
| Pfizer INC. | $28.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.